Clinical Trial Update: Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the safety and tolerability of intravenous SPM 927 as a replacement for oral SPM 927 in subjects with partial seizures, ba…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• SPM 927 (SPM 927)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsies, Partial | Phase 2, Phase 3 | Status: COMPLETED